NAN NAN
Company Profile ↓Company Overview
NAN (NAN) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.00.
Recent Developments
- Aug 2025 Revenue of $-21.98M (-181.4% YoY); net profit $-23.15M.
- Trailing 12 Months Year-on-year growth — revenue -181.4%, earnings -189.2%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | - |
| 1 Year: | -181.38% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -189.23% |
Stock Price Performance
| 1 Year: | +4.49% |
| 6 Months: | -4.12% |
| 3 Months: | -4.68% |
| 1 Month: | -3.44% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)27.84 · Oversold
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Profit & Loss (Annual)
Figures in USD.
| Metric | Feb 2022 | Feb 2023 | Feb 2024 | Aug 2025 |
|---|---|---|---|---|
| Revenue | -731.37K | -56.83M | 27.01M | -21.98M |
| Cost of Revenue | - | - | - | - |
| Gross Profit | - | - | - | - |
| Operating Expenses | 1.08M | 1.11M | 1.07M | 1.17M |
| Operating Income | - | - | - | - |
| EBITDA | - | - | - | - |
| Interest Expense | 1.75M | 5.73M | 9.74M | 8.90M |
| Pretax Income | -1.82M | -57.94M | 25.94M | -23.15M |
| Tax Provision | - | - | - | - |
| Net Income | -1.82M | -57.94M | 25.94M | -23.15M |
| Diluted EPS | -0.06 | -1.88 | 0.85 | -0.75 |
Ratios (Annual)
Figures in %.
| Metric | Feb 2022 | Feb 2023 | Feb 2024 | Aug 2025 |
|---|---|---|---|---|
| Gross Margin % | - | - | - | - |
| Operating Margin % | - | - | - | - |
| Net Margin % | 248.2% | 102.0% | 96.0% | 105.3% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NAN
Municipal bond fund NAN (NYSE: NAN) lines up a fresh pool of shares, preferreds and rights for future offerings - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxQXzlKM01peDJtbEZYRzF5QkxpNEhBQi0ydENzWU84SUNPN0hYZzNLUktVdmYyU1ZQb29ORGY1TFBQOWk1STRYZWxOSlpZWWVQNV9fcFIzWXR2UUc5RnlTRFdudzUxY2NRRUJNMDl6THIyVEFzMExTcEhvQWRMeXZkbTJfcUYwU2luYjZMYV…
Nan Shan Life Insurance Co. Ltd. Buys 55,409 Shares of Analog Devices, Inc. $ADI - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMi0AFBVV95cUxNSEJoUUhEVlhkSzlPLUZLVjFRRGxTRlVsdUJmbkp0c3ptb3NKemJBY2xLX19sNzA2S3NOYS1Mb0JKM2NQQ3E0dDhxeDNqOHhpY0xURGlrQnU3ZEVBeTA5c3RhcWIyazA2akcxNkxKb0Z0T0g3SEZTVFBETEhPQW9vWlRoRW0tQ0plNDFIRH…
(NAN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxONmJ5SEQ2MERaNWlCa2ZJVDZ3SHdORGZCSHRES0JHYjNreVAwYzBKS0c2NjctVzVCcFNVRXpHQU13bG5RdEk2T1p3Z0xNRlVLLU5SQWVWZ3FQOEhDcVlFekdIY29xTkVHQmtxQ3Y3OUpEYjQ2YUVCWmU5LXEyMkhhWjE3c2VqMGhESzk5Z3…
Nan Fung Group Sells $4.3 Million in Oculis Shares As Lead Drug Stumbles - The Motley Fool
<a href="https://news.google.com/rss/articles/CBMiwgFBVV95cUxORDBNZVd4YURjMWdSd2tWV1Q0ZFZaLUJhTkc1TkVoNXpBd1RleG02S1hDeWZyU1NmaktCR215a1hnVU9kaFh3YVRpOF9ENHJYelZuZG9fTjlmaDdWS2FKX25tX3p0bGNpS0lLaUpDTmVZcFJzdFRuVjAwM1lXbEpLZGNPRU16MWtDb0V3MX…
Nanosonics (ASX:NAN) Up 2.18% — Should You Add This Infection Prevention Stock to Your Watchlist? - Kalkine
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxQMFRNNUg1dkNIOWdJOW5BdEVkRmFFd2o4S1lXcEd4LVJJYUhXeWxCZHVwOUlYb2dmRVRvektIdFh2R0UwWnRZd1NJSF9nMG5FZHN4NVM5ZU1MeXA4RElMUmtPSVZHXzItelNZVk9tMGJZeHFJb1VnUndrYUNFTl9hcjB1OFNXX0ZpRnRiTl…
Freeport-McMoRan Inc. $FCX Shares Purchased by Nan Shan Life Insurance Co. Ltd. - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMi0gFBVV95cUxOOExzU09yVzN4WjZRamRuMlBDeU0ySlZCdk0tcU8zVTRfZktTUmNrVW9QcVd2blNDa3ZuRlRaRTFvZ0lONTlIbGJ6dHExMzRZT3lyUjRFUkRSM1A3bDdKM25WQnZvelJrV19ON3B0bW16VHNnVGs4YnZCRUIwbTRycnl0ZnptTU1lVnBkaH…
NAN — Frequently Asked Questions
What is the current share price of NAN?
As of 2026-09-07 16:24 PDT, NAN trades at $10.75 on NASDAQ/NYSE. Its 52-week range is $10.29 to $11.63.
What is the P/E ratio of NAN?
NAN trades at a trailing price-to-earnings (P/E) ratio of -14.33.
Is NAN a good stock to buy?
This page provides a data-driven analysis of NAN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.